Suchergebnisse - "Peter L Anderson"

PubPharm (17)

1

Development and Evaluation of Nanoparticles-in-Film Technology to Achieve Extended In Vivo Exposure of MK-2048 for HIV Prevention

in: Polymers | 2022

von Xin Tong | Sravan Kumar Patel | Jing Li | +8

2

Usability and effectiveness of adherence monitoring of a mobile app designed to monitor and improve adherence to event-driven and daily HIV pre-exposure prophylaxis among men who have sex with men in Taiwan

in: Digital Health | 2022

von Huei-Jiuan Wu | Yi-Fang Yu | Stephane Wen-Wei Ku | +7

3

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

in: Therapeutic Advances in Infectious Disease | 2022

von Yeba H. Adje | Kristina M. Brooks | Jose R. Castillo-Mancilla | +3

4

The Magnetic Couples Study: protocol for a mixed methods prospective cohort study of HIV-serodifferent heterosexual couples’ perspectives and use of pre-exposure prophylaxis (PrEP)

in: BMJ Open | 2021

von Graham Harriman | Ann Kurth | James M. McMahon | +15

5

Beyond HIV viral load: application of pharmacologic measures to identify ART adherence mismatch

in: Therapeutic Advances in Infectious Disease | 2021

von Michael Kristofich | Peter L. Anderson | Jose R. Castillo-Mancilla

6

PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.

in: PLoS Medicine | 2021

von Connie Celum | Sybil Hosek | Mandisa Tsholwana | +19

7

Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion

in: International Journal of Infectious Diseases | 2020

von Shui-Shan Lee | Peter L. Anderson | Tsz-Ho Kwan | +5

8

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV

in: Frontiers in Pharmacology | 2020

von Max von Kleist | Max von Kleist | J. Gerardo García-Lerma | +2

9

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

in: Pharmaceutics | 2020

von Fernanda P. Pons-Faudoa | Nicola Di Trani | Antons Sizovs | +15

10

Moderately High Tenofovir Diphosphate in Dried Blood Spots Indicates Drug Resistance in Viremic Persons Living with HIV

in: Journal of the International Association of Providers of AIDS Care | 2019

von Jenna Lynn Yager PharmD | Ryan Patrick Coyle BA | Stacey Summer Coleman BS, B. | +9